Outcome of relapsed or refractory acute B-lymphoblastic leukemia patients and BCR-ABL-positive blast cell crisis of B-lymphoid lineage with extramedullary disease receiving inotuzumab ozogamicin - Kayser, Sabine; Sartor, Chiara; Luskin, Marlise R.; Webster, Jonathan; Giglio, Fabio; Panitz, Nydia; Brunner, Andrew M.; Fante, Matthias; Lutz, Christoph; Wolff, Daniel; Ho, Anthony Dick; Levis, Mark J.; et al. (Haematologica, 2022)
Gesehen am 09.05.2023